<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">1</item><item key="sample_count">31</item><item key="tags"><item>adenocarcinomas</item><item>cancer</item><item>cell</item><item>epithelial cell</item><item>line</item><item>prostate</item><item>prostate cancer</item><item>protein</item></item><item key="slug">expression-data-from-lncap-cell-line-treated-with</item><item key="geo_gse_id">E-GEOD-27914</item><item key="id">3994</item><item key="species">human</item><item key="name">Expression data from LNCap cell line treated with COP1 (RFWD2), ETV1, and JUN siRNAs</item></item><item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>trophoblast</item></item><item key="slug">expression-data-from-htr-8svneo-side-population-sp</item><item key="geo_gse_id">E-GEOD-27909</item><item key="id">3993</item><item key="species">human</item><item key="name">Expression data from HTR-8/Svneo side population (SP) and non-side population (NSP) cells</item></item><item><item key="factor_count">4</item><item key="sample_count">35</item><item key="tags"><item>atopic dermatitis</item><item>dermatitis</item><item>disease</item><item>psoriasis</item><item>skin</item><item>skin disease</item></item><item key="slug">reversal-of-atopic-dermatitis-with-narrow-band-uvb</item><item key="geo_gse_id">E-GEOD-27887</item><item key="id">3992</item><item key="species">human</item><item key="name">Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response</item></item><item><item key="factor_count">2</item><item key="sample_count">56</item><item key="tags"><item>chronic lymphocytic leukemia</item><item>leukemia</item><item>peripheral</item></item><item key="slug">the-novel-antisense-bcl-2-inhibitor-spc2996-causes</item><item key="geo_gse_id">E-GEOD-27858</item><item key="id">3991</item><item key="species">human</item><item key="name">The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia</item></item><item><item key="factor_count">2</item><item key="sample_count">32</item><item key="tags"><item>cell</item><item>genome</item><item>immune system</item><item>membrane</item><item>myeloma</item><item>peripheral</item></item><item key="slug">gene-expression-of-expanded-and-non-expanded-natur</item><item key="geo_gse_id">E-GEOD-27838</item><item key="id">3990</item><item key="species">human</item><item key="name">Gene expression of expanded and non-expanded natural killer cells from healthy donor and myeloma patients</item></item><item><item key="factor_count">2</item><item key="sample_count">29</item><item key="tags"><item>cancer</item><item>liver</item><item>melanoma</item><item>protein</item><item>scid</item><item>syndecan</item><item>uveal melanoma</item></item><item key="slug">syntenin-1-is-expressed-in-uveal-melanoma-and-corr</item><item key="geo_gse_id">E-GEOD-27831</item><item key="id">3989</item><item key="species">human</item><item key="name">Syntenin-1 is expressed in uveal melanoma and correlates with metastatic progression</item></item><item><item key="factor_count">2</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>cell</item><item>cytokine</item><item>line</item><item>melanoma</item><item>point</item></item><item key="slug">mir-30b30d-regulation-of-galnac-transferases-enhan</item><item key="geo_gse_id">E-GEOD-27718</item><item key="id">3988</item><item key="species">human</item><item key="name">MiR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis</item></item><item><item key="factor_count">6</item><item key="sample_count">40</item><item key="tags"><item>adenocarcinoma</item><item>carcinoma</item><item>cell</item><item>cell morphology</item><item>lung</item><item>lung adenocarcinoma</item></item><item key="slug">expression-data-from-columbia-lung-adenocarcinoma</item><item key="geo_gse_id">E-GEOD-27716</item><item key="id">3987</item><item key="species">human</item><item key="name">Expression data from Columbia Lung Adenocarcinoma Human Tumor Cells</item></item><item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"/><item key="slug">molecular-profiles-for-gtl16-cell-lines</item><item key="geo_gse_id">E-GEOD-27692</item><item key="id">3986</item><item key="species">human</item><item key="name">Molecular profiles for GTL16 cell lines</item></item><item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cell</item></item><item key="slug">down-regulation-of-blimp1-alpha-by-the-ebv-oncogen</item><item key="geo_gse_id">E-GEOD-27670</item><item key="id">3984</item><item key="species">human</item><item key="name">Down-regulation of BLIMP1-alpha by the EBV oncogene, LMP1, disrupts the plasma cell differentiation program and prevents viral replication in B cells</item></item></data></biogps>
